Ani Pharmaceuticals reported $-3562000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Aerie Pharmaceuticals AERI:US $ -32.37M 0.87M
Ani Pharmaceuticals ANIP:US $ -3562000 11.99M
Aurora Cannabis Inc ACB:CN -40797000 112.66M
Biodelivery Sciences International BDSI:US $ 15.62M 4.25M
Canopy Growth Corp WEED:CN C$ -215359000 25.31M
Depomed DEPO:US $ 5.93M 17.93M
Eli Lilly And LLY:US $ 1476M 72.6M
Emergent Biosolutions EBS:US $ -34.7M 49.2M
Endo International Ordinary Shares ENDP:US $ 89.16M 53.95M
Flexion Therapeutics FLXN:US $ -23658000 6.78M
Heron Therapeutics HRTX:US $ -51.71M 8.76M
Hikma Pharmaceutical HIK:LN 343M 34M
Knight Therapeutics Inc GUD:CN C$ 4.11M 3.92M
Lannett LCI:US $ -8.15M 25.68M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Novartis NVS:US $ 3233M 246M
Omeros OMER:US $ -18253000 5.76M
Perrigo Ordinary Shares PRGO:US $ 438.3M 564.2M
Sun Pharmaceuticals SUNP:IN IR 21759.2M 5690.1M
Teva Pharmaceutical TEVA:IT 623M 41M
Teva Pharmaceutical Industries TEVA:US $ 623M 41M